Literature DB >> 22654013

Supine volume drop and diaphragmatic function in adults with Pompe disease.

Hélène Prigent, David Orlikowski, Pascal Laforêt, Nadège Letilly, Line Falaize, Nadine Pellegrini, Djillali Annane, Jean-Claude Raphael, Frédéric Lofaso.   

Abstract

Mesh:

Year:  2012        PMID: 22654013     DOI: 10.1183/09031936.00169011

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  21 in total

1.  Safety and efficacy of short- and long-term inspiratory muscle training in late-onset Pompe disease (LOPD): a pilot study.

Authors:  Stephan Wenninger; Eva Greckl; Haris Babačić; Kristina Stahl; Benedikt Schoser
Journal:  J Neurol       Date:  2018-11-14       Impact factor: 4.849

2.  Respiratory muscle training in late-onset Pompe disease: Results of a sham-controlled clinical trial.

Authors:  Harrison N Jones; Maragatha Kuchibhatla; Kelly D Crisp; Lisa D Hobson-Webb; Laura Case; Milisa T Batten; Jill A Marcus; Richard M Kravitz; Priya S Kishnani
Journal:  Neuromuscul Disord       Date:  2020-09-28       Impact factor: 4.296

3.  Respiratory function in late-onset Pompe disease patients receiving long-term enzyme replacement therapy for more than 48 months.

Authors:  Ilka Schneider; Frank Hanisch; Tobias Müller; Bernd Schmidt; Stephan Zierz
Journal:  Wien Med Wochenschr       Date:  2012-11-19

4.  Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease.

Authors:  Dwight D Koeberl; Laura E Case; Edward C Smith; Crista Walters; Sang-Oh Han; Yanzhen Li; Wei Chen; Christoph P Hornik; Kim M Huffman; William E Kraus; Beth L Thurberg; David L Corcoran; Deeksha Bali; Nenad Bursac; Priya S Kishnani
Journal:  Mol Ther       Date:  2018-07-05       Impact factor: 11.454

Review 5.  The respiratory neuromuscular system in Pompe disease.

Authors:  David D Fuller; Mai K ElMallah; Barbara K Smith; Manuela Corti; Lee Ann Lawson; Darin J Falk; Barry J Byrne
Journal:  Respir Physiol Neurobiol       Date:  2013-06-21       Impact factor: 1.931

6. 

Authors:  Harrison N Jones; Maragatha Kuchibhatla; Kelly D Crisp; Lisa D Hobson Webb; Laura Case; Milisa T Batten; Jill A Marcus; Richard M Kravitz; Priya S Kishnani
Journal:  Mol Genet Metab       Date:  2019-05-08       Impact factor: 4.797

7.  The impact of interrupting enzyme replacement therapy in late-onset Pompe disease.

Authors:  Stephan Wenninger; Kristina Gutschmidt; Corinna Wirner; Krisztina Einvag; Federica Montagnese; Benedikt Schoser
Journal:  J Neurol       Date:  2021-02-24       Impact factor: 4.849

8.  Sleep-Disordered Breathing and Effects of Noninvasive Ventilation in Patients with Late-Onset Pompe Disease.

Authors:  Matthias Boentert; Bianca Dräger; Christian Glatz; Peter Young
Journal:  J Clin Sleep Med       Date:  2016-12-15       Impact factor: 4.062

9.  Altered activation of the diaphragm in late-onset Pompe disease.

Authors:  Barbara K Smith; Manuela Corti; A Daniel Martin; David D Fuller; Barry J Byrne
Journal:  Respir Physiol Neurobiol       Date:  2015-11-28       Impact factor: 1.931

10.  Peripheral nerve and neuromuscular junction pathology in Pompe disease.

Authors:  Darin J Falk; Adrian Gary Todd; Sooyeon Lee; Meghan S Soustek; Mai K ElMallah; David D Fuller; Lucia Notterpek; Barry J Byrne
Journal:  Hum Mol Genet       Date:  2014-09-12       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.